Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-001169
Filing Date
2025-02-14
Accepted
2025-02-14 16:22:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9040
  Complete submission text file 0001172661-25-001169.txt   10766
Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

EIN.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Subject) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86603 | Film No.: 25629321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)